Literature DB >> 21506569

Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.

Naama Hen1, Meir Bialer, Boris Yagen, Alfonso Maresca, Mayank Aggarwal, Arthur H Robbins, Robert McKenna, Andrea Scozzafava, Claudiu T Supuran.   

Abstract

Aromatic amides comprising branched aliphatic carboxylic acids and 4-aminobenzenesulfonamide were evaluated for their inhibition of carbonic anhydrase (CA) isoforms. Of the most anticonvulsant-active compounds (2, 4, 13, 16, and 17), only 13, 16, and 17 were potent inhibitors of CAs VII and XIV. Compounds 9, 14, and 19 inhibited CA II, while 10 and 12 inhibited all isoforms. Structural studies suggest that differences in the active sites' hydrophobicity modulate the affinity of the inhibitors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506569     DOI: 10.1021/jm200209n

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Discovery of New 1,1'-Biphenyl-4-sulfonamides as Selective Subnanomolar Human Carbonic Anhydrase II Inhibitors.

Authors:  Giuseppe La Regina; Michela Puxeddu; Marianna Nalli; Daniela Vullo; Paola Gratteri; Claudiu Trandafir Supuran; Alessio Nocentini; Romano Silvestri
Journal:  ACS Med Chem Lett       Date:  2019-11-11       Impact factor: 4.345

Review 2.  Emerging trends in environmental and industrial applications of marine carbonic anhydrase: a review.

Authors:  Sudabeh Iraninasab; Sana Sharifian; Ahmad Homaei; Mozafar Bagherzadeh Homaee; Tanvi Sharma; Ashok Kumar Nadda; John F Kennedy; Muhammad Bilal; Hafiz M N Iqbal
Journal:  Bioprocess Biosyst Eng       Date:  2021-11-25       Impact factor: 3.210

3.  Carbonic anhydrase inhibitors: design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives.

Authors:  Jayashree Pichake; Prashant S Kharkar; Mariangela Ceruso; Claudiu T Supuran; Mrunmayee P Toraskar
Journal:  ACS Med Chem Lett       Date:  2014-05-16       Impact factor: 4.345

4.  Insights towards sulfonamide drug specificity in α-carbonic anhydrases.

Authors:  Mayank Aggarwal; Bhargav Kondeti; Robert McKenna
Journal:  Bioorg Med Chem       Date:  2012-08-28       Impact factor: 3.641

5.  Lucky Switcheroo: Dramatic Potency and Selectivity Improvement of Imidazoline Inhibitors of Human Carbonic Anhydrase VII.

Authors:  Stanislav Kalinin; Stanislav Kopylov; Tiziano Tuccinardi; Alexander Sapegin; Dmitry Dar'in; Andrea Angeli; Claudiu T Supuran; Mikhail Krasavin
Journal:  ACS Med Chem Lett       Date:  2017-09-15       Impact factor: 4.345

6.  A class of 4-sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects.

Authors:  Murat Bozdag; Melissa Pinard; Fabrizio Carta; Emanuela Masini; Andrea Scozzafava; Robert McKenna; Claudiu T Supuran
Journal:  J Med Chem       Date:  2014-11-10       Impact factor: 7.446

7.  A class of carbonic anhydrase I - selective activators.

Authors:  Erol Licsandru; Muhammet Tanc; Istvan Kocsis; Mihail Barboiu; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2016-11-01       Impact factor: 5.051

Review 8.  Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase.

Authors:  Alessio Nocentini; Andrea Angeli; Fabrizio Carta; Jean-Yves Winum; Raivis Zalubovskis; Simone Carradori; Clemente Capasso; William A Donald; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

Review 9.  Insights into Potential Targets for Therapeutic Intervention in Epilepsy.

Authors:  Cecilia Zavala-Tecuapetla; Manola Cuellar-Herrera; Hiram Luna-Munguia
Journal:  Int J Mol Sci       Date:  2020-11-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.